[HTML][HTML] A simplified SARS-CoV-2 mouse model demonstrates protection by an oral replicon-based mRNA vaccine

V Jawalagatti, P Kirthika, C Hewawaduge… - Frontiers in …, 2022 - frontiersin.org
A mouse model of SARS-CoV-2 that can be developed in any molecular biology lab with
standard facilities will be valuable in evaluating drugs and vaccines. Here we present a …

A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine.

V Jawalagatti, P Kirthika, C Hewawaduge… - Frontiers in …, 2022 - europepmc.org
A mouse model of SARS-CoV-2 that can be developed in any molecular biology lab with
standard facilities will be valuable in evaluating drugs and vaccines. Here we present a …

[PDF][PDF] A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine

V Jawalagatti, P Kirthika, C Hewawaduge… - Front. Immunol. 13 …, 2022 - researchgate.net
A mouse model of SARS-CoV-2 that can be developed in any molecular biology lab with
standard facilities will be valuable in evaluating drugs and vaccines. Here we present a …

A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine

V Jawalagatti, P Kirthika… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
A mouse model of SARS-CoV-2 that can be developed in any molecular biology lab with
standard facilities will be valuable in evaluating drugs and vaccines. Here we present a …

[HTML][HTML] A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine

V Jawalagatti, P Kirthika, C Hewawaduge… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
A mouse model of SARS-CoV-2 that can be developed in any molecular biology lab with
standard facilities will be valuable in evaluating drugs and vaccines. Here we present a …

[PDF][PDF] A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine

V Jawalagatti, P Kirthika, C Hewawaduge… - Front. Immunol. 13 …, 2022 - scienceopen.com
A mouse model of SARS-CoV-2 that can be developed in any molecular biology lab with
standard facilities will be valuable in evaluating drugs and vaccines. Here we present a …

A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine.

V Jawalagatti, P Kirthika, C Hewawaduge… - Frontiers in …, 2022 - europepmc.org
A mouse model of SARS-CoV-2 that can be developed in any molecular biology lab with
standard facilities will be valuable in evaluating drugs and vaccines. Here we present a …